Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
McCourt Marion sold 2,346 Regeneron Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 2 to Sep 3, 2026 · Filed Sep 3, 2026
From Sep 2 to Sep 3, 2026, McCourt Marion (EVP Commercial) sold 2,346 Regeneron Pharmaceuticals, Inc. shares at an average US$853.56 for US$2M under a trading plan, leaving 12,003 shares. Filed Sep 3, 2026 (Form 4).
- Sold
- 2,346 shares
- Price
- US$853.56 average (US$850.00 to US$857.39)
- Value
- US$2M
- Holding after
- 12,003 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP Commercial
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Common Stock | Sale | 1,215 | US$850.00 | 13,134 | Direct |
| Sep 3, 2026 | Common Stock | Sale | 1,131 | US$857.39 | 12,003 | Direct |